Lack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury
Robert Faulhaber‐Walter(Medizinische Hochschule Hannover), Jürgen Schnermann(National Institutes of Health), Diane Mizel(National Institute of Diabetes and Digestive and Kidney Diseases), Limeng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Josephine P. Briggs(University of Michigan), Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Noriyuki Hiramatsu, Patricia M. Zerfas(Office of Research Services), Hiroshi Kajiyama(National Institutes of Health), Mona Oppermann, Yuning Huang(National Institutes of Health), Soo Mi Kim(Jeonbuk National University Hospital)
Cited by 89
Related Papers
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
|Journal of the American Society of Nephrology|2004|853
Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture
|Nature Neuroscience|2010|802
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706